During Wednesday’s trading session, the shares of a renowned pharmaceutical company surged by nearly 1.4 percent to Rs. 565 on NSE, after the company announced receiving Product Registration License for one of its products in Myanmar.
With a market cap of Rs. 1,539.6 crores, at 11:16 a.m., the shares of Zota Health Care Limited were trading in the green at Rs. 561.75, up by nearly 0.8 percent, as compared to its previous closing price of Rs. 557.4.
What’s the news:
According to the latest regulatory filings with the NSE, Zota Health Care has obtained a Product Registration License for one of its products from the Ministry of Health Department of Food and Drug Administration, Myanmar.
The company was granted the license for the product “S-AMLOZED 5,” with each uncoated tablet containing S-Amlodipine Besilate equivalent to S-Amlodipine 5mg, classified under the Therapeutic Category of Calcium Channel Blockers.
The Product Registration License is valid for a period of five years, after which it may be renewed. The company plans to begin exporting these products to Myanmar in the near future.
Financials:
Zota Health Care reported a significant growth in revenue from operations, experiencing a year-on-year increase of nearly 49 percent, rising from Rs. 45 crores in Q2 FY24 to Rs. 67 crores in Q2 FY25.
In contrast, during the same period, the company’s net loss increased from Rs. 2 crores to Rs. 12 crores, representing a decline of around 500 percent YoY.
Also read….
Shareholding Pattern:
As per the September 2024 shareholding pattern, the Promoters hold a 62.4 percent stake in the company, Foreign Institutional Investors (FII) hold a 0.01 percent stake, while Retail Investors and Domestic Institutional Investors (DII) hold a 36.6 percent and 0.99 percent stake in Zota Health Care, respectively.
Stock Performance:
The stock has delivered positive returns of nearly 36 percent in one year, as well as around 19.5 percent returns in the last six months. So far in 2024, the shares of Zota Health Care have given positive returns of about 17 percent.
About the company:
Founded in 2000, Zota Health Care Limited is established as a drug development, manufacturing and marketing company. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic and OTC products. The company caters to both domestic and international markets.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
